StockNews.com assumed coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Price Performance
CPIX stock opened at $1.29 on Friday. The company has a market capitalization of $18.19 million, a P/E ratio of -2.19 and a beta of 0.20. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.26 and a current ratio of 1.44. Cumberland Pharmaceuticals has a 52-week low of $1.27 and a 52-week high of $2.36. The business has a 50-day simple moving average of $1.41 and a two-hundred day simple moving average of $1.56.
About Cumberland Pharmaceuticals
Further Reading
- Five stocks we like better than Cumberland Pharmaceuticals
- Canada Bond Market Holiday: How to Invest and Trade
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- 3 Stocks to Consider Buying in October
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- How to Calculate Inflation Rate
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.